CD276 and neoplasm: This speculation is highly echoed by the fact that the receptor on immune cells for B7‐H3 is still not found yet despite the tremendous efforts from a lots of immunology labs, and the precise mechanism by which it mediates tumor immune evasion remains unclear, rendering the PD‐1 equivalent receptor on CD8+ T cells serving for B7‐H3 absence.